MIT Laboratory / PAREXEL / J.A. (2010) Pharmaceutical / Thomson Reuters / Artificial Intelligence Laboratory / State Street / Oxford University Press / Pfizer / Elsevier Ltd. / Harvard Business School Press / Creative Commons / J. Pharm / Humana Press / /
Country
United States / /
Currency
USD / / /
Event
FDA Phase / /
Facility
MIT Operations Research Center / Whitehead Institute / /
IndustryTerm
venture capital / biotechnology / pharmaceutical industry / pharmaceutical / simulation software / /
School of Management / MIT / Harvard / Congress / FDA / Oxford University / /
Person
Stelios Papadopoulos / Pisano / Nat / Chris Austin / Larry Nagahara / Kevin Wen / Jonathan Franca-Koh / Larry Norton / Chris Adams / Jim Broderick / Doug Treco / Nora Yang / Harvey Lodish / John McKew / / /
Position
G.P. / original author / http /
Product
pseudo / Orphan Drug / Rituxan1 / PERSPECTIVE / Thomson Reuters / Phase I compounds / /
ProvinceOrState
Indiana / New York / /
PublishedMedium
Elsevier / Parameters / /
Technology
biotechnology / pdf / drug discovery / genetic code / http / simulation / drug development / /
This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar